ÂÜÀòÂÒÂ×

Oriana Papin-Zoghbi is the CEO and Co-Founder of AOA Dx, a biotech company focused on early-stage cancer detection, which has partnered with McGill University to develop a liquid biopsy diagnostic test for ovarian cancer. In addition to leading AOA Dx since September 2019, Oriana serves as a START Judge for MassVentures, a mentor for MassBio's MassCONNECT program, and is a member of the Young Entrepreneur Council. Oriana previously held executive roles at noteworthy companies including Trophi GmbH, CELLINK, and Parsagen Diagnostics, contributing significantly to business development and sales growth in the biotech and life sciences sectors. Oriana's educational background includes participation in Y Combinator and a Bachelor's degree in Economics and International Relations from Boston University.